812
Views
8
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Purification and partial characterization of the extradiol dioxygenase, 2′-carboxy-2,3-dihydroxybiphenyl 1,2-dioxygenase, in the fluorene degradation pathway from Rhodococcus sp. strain DFA3

, , , , &
Pages 719-725 | Received 08 Sep 2015, Accepted 10 Nov 2015, Published online: 21 Jan 2016
 

Abstract

Type II extradiol dioxygenase, 2′-carboxy-2,3-dihydroxybiphenyl 1,2-dioxygenase (FlnD1D2) involved in the fluorene degradation pathway of Rhodococcus sp. DFA3 was purified to homogeneity from a heterologously expressing Escherichia coli. Gel filtration chromatography and SDS-PAGE suggested that FlnD1D2 is an α4β4 heterooctamer and that the molecular masses of these subunits are 30 and 9.9 kDa, respectively. The optimum pH and temperature for enzyme activity were 8.0 and 30 °C, respectively. Assessment of metal ion effects suggested that exogenously supplied Fe2+ increases enzyme activity 3.2-fold. FlnD1D2 catalyzed meta-cleavage of 2′-carboxy-2,3-dihydroxybiphenyl homologous compounds, but not single-ring catecholic compounds. The Km and kcat/Km values of FlnD1D2 for 2,3-dihidroxybiphenyl were 97.2 μM and 1.5 × 10−2 μM−1sec−1, and for 2,2′,3-trihydroxybiphenyl, they were 168.0 μM and 0.5 × 10−2 μM−1sec−1, respectively. A phylogenetic tree of the large and small subunits of type II extradiol dioxygenases suggested that FlnD1D2 constitutes a novel subgroup among heterooligomeric type II extradiol dioxygenases.

Graphical abstract

Type II extradiol dioxygenases (EDOs) are classified into 5 subgroups, and FlnD1D2 constitutes the distinct group from previously investigated EDOs.

Disclosure statement

No potential conflict of interest was reported by the authors.

Notes

Abbreviations: Ap, ampicillin; DF, dibenzofuran; FN, fluorene; km, kanamycin; LB, Luria–Bertani; PAHs, polycyclic aromatic hydrocarbons; SD, Shine–Dalgarno; 2,2′,3-THBP, 2,2′,3-trihydroxybipenyl, 2,3-DHBP, 2,3-dihydroxybiphenyl; 2′-carboxy-2,3-DHBP, 2′-carboxy-2,3-dihydroxybiphenyl.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.